NCT00109356View on ClinicalTrials.gov

Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

March 31, 2007

Conditions
Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
Interventions
DRUG

AQ4N (Chemotherapy)

Trial Locations (1)

10021

Weill Medical College of Cornell University/ New York Presbyterian Hospital, New York

Sponsors

Lead Sponsor

Novacea
All Listed Sponsors
lead

Novacea

INDUSTRY

NCT00109356 - Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter